MedTrace Logo

China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project

NCT05316805 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2024-08-15

No results posted yet for this study

Summary

In order to further improve the diagnosis and treatment level of type 2 inflammatory skin diseases, the National Clinical Center for Skin and Immune Diseases established a standardized diagnosis and treatment center for type 2 inflammatory skin diseases to systematically and effectively understand the current treatment status of patients with type 2 inflammatory skin diseases, as well as the efficacy and safety of various treatment methods during practices, so as to further improve the diagnosis and treatment level of type 2 inflammatory skin diseases and help patients with type 2 inflammatory skin diseases.

Conditions

  • Atopic Dermatitis Eczema
  • Prurigo Nodularis

Sponsors & Collaborators

  • Peking University First Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-31
Primary Completion
2031-12-31
Completion
2031-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05316805 on ClinicalTrials.gov